Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Aryeh currently holds 42,553 shares of Orchestra BioMed Holdings, Inc. (OBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Aryeh has been a net seller of OBIO stock. They have purchased $5.6M and sold $39.8M worth of shares.
Jason Aryeh's most recent insider trade was on Jun 23, 2026, when they sold 42,553 shares at $0.00 per share.
Jason Aryeh serves as Executive at Orchestra BioMed Holdings, Inc. (OBIO). They have executed 275 insider transactions totaling $45.3M over their tenure at the company.
Jason Aryeh holds the position of Executive at Orchestra BioMed Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jason Aryeh has shown a selling trading pattern, with $5.6M in total purchases and $39.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Aryeh was on Jun 11, 2026, when they sold $1.1M worth of LGND shares. This transaction involved 4,500 shares at $250.00 per share.
Jason Aryeh currently owns 42,553 shares of Orchestra BioMed Holdings, Inc. (OBIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Aryeh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Aryeh has 275 Form 4 filings on record as an insider at Orchestra BioMed Holdings, Inc..
Set alerts for Jason Aryeh and 40,000+ other insiders.